Try our Advanced Search for more refined results
Health - June, 2011
228 articles
- 3rd Circ. Revives United Health Kickback Claim
- Medicare Will Cover Avastin Despite FDA Ruling
- Elan, Abbott Drop Teva Patent Suit Over Tricor
- ViiV Goes After Lupin Over HIV Drug ANDA
- Spotlight On Corporate Governance Rules For Insurers
- Same-Sex Marriage And NY Employee Benefits
- Merck, Sandoz Resolve Patent Suit Over Cancidas
- Impax Settles With Daiichi, Genzyme Over Generic Welchol
- Signalife, Investors Seek Approval For $4M Settlement
- Ex-Bio-Med Execs Can't Escape Convictions: 11th Circ.
- 3rd Circ. OKs State Liens On Medicaid Patient Awards
- HHS Subpoenas HealthSouth Over Medicare Fraud
- Somaxon Sues Mylan Again Over Generic Silenor
- FDA Panel Rules Avastin Unsafe For Breast Cancer Use
- 6th Circ. Backs Health Care Reform's Individual Mandate
- A Practical Guide To Discovery Conference Preparation
- EU, South Korea FTA To Address Nontariff Barriers
- Wilson Sonsini Snags Pharma Patent Pro From Foley
- Getting Specific About FCPA Compliance
- Doctors Blast Rosy Research For Medtronic Bone Device
- Judge Agrees With Watson's Take On Lidoderm Patent
- Roche Files 3 Patent Suits Over Generic Xeloda
- Pfizer Fights Aurobindo's Bid To Sell Generic Lipitor
- Barnes & Thornburg Adds 7 Akin Gump Attorneys In LA
- Medtronic Sues Edwards Over Heart Valve Patents
- Icahn Sues Forest Labs Over CEO Defense
- Quarles & Brady Adds Employee Benefits Atty In Wis.
- Experian To Buy Medical Billing Co. For $185M
- Judge Tosses FTC Suit Challenging Hospital Merger
- Mylan Takes $76M Antitrust Verdict To High Court
- UnitedHealth Seeks 2nd Remand Of GSK Paxil Action
- APP Takes Patent Contract Ruling To High Court
- New Charges Coming In Hospital Bribery Case, Feds Say
- AstraZeneca Sues Watson Over Generic Pulmicort
- Q&A With Much Shelist's Edward Shapiro
- Questions Remain On Class Certification Relitigation
- Zyprexa Payors' Off-Label Suit Denied By High Court
- GE Settles In $30M Radioactive Cleanup Suit
- Prandin Use Code Case Taken Up By High Court
- Atty Can't Represent AWP Classes, 1st Circ. Rules
- FDA Strengthens Warnings On Amgen, J&J Anemia Drugs
- W.Va. Supreme Court Revives Mylan Forum Challenge
- St. Jude Wins Injunction, Verdict Trimmed By $1.3B
- LeClairRyan Adds Roetzel White Collar Atty In DC
- 2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
- How To Make It Rain By Marketing Individual Lawyers
- Mylan Crohn's Drug Doesn't Infringe AstraZeneca IP: Judge
- Novelos Shakes Class Action Over Cancer Drug Statements
- UnitedHealth Wins Access To GSK Litigation Info
- Novo Hit With Overtime, Break Action From Sales Rep
- Ceridian Sues Zeitgeist For $3.5M Over Guard Contract
- ConvaTec Dodges Hollister Incontinence Device IP Suit
- Teva Targets Apotex Over Generic Parkinson's Drug
- GSK To Pay States, DC $41M Over Drugmaking Lapses
- UnitedHealth To Pay $1M For Antitrust Pact Breach
- Modifying HIPAA Disclosure Accounting Provisions
- High Court Ruling May Hobble Suits Against Generics
- Smith & Nephew Wins $85M IP Verdict Against Arthrex
- Covidien Sales Rep OT Suit Should Be Certified: Judge
- Hospira Sued Over Infusion Patent, Sale Contract
- Feds Seek 30 Years For Doctor In $23M Medicare Fraud
- Mylan Resolves Shire Suit Over Generic Fosrenol
- Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
- Breast Implants Aren't Forever, FDA Warns
- Understanding The Advice-Of-Counsel Defense
- Judge OKs Replacement Of Dead Class Rep In Paxil Suit
- Sens. Order Medtronic To Turn Over Infuse Records
- Skadden Reps Dentsply In $1.8B AstraZeneca Unit Buy
- Transgender Court Clerk Sues Ore. For Coverage Denial
- House To Debate Diversion Of USPTO Fees
- UnitedHealth Sues DOD Over $24B Healthcare Contract
- Claims Cut From Ex-Eisai Worker's Whistleblower Suit
- FDA Wants Relaxed Sterility Test Rules For Bio Products
- Anthem Blue Cross Settles Policy Closure Action
- The FTC's War On 'Pay-For-Delay' Agreements
- Astellas Hits Sagent, Strides With Adenoscan IP Suit
- Sanofi Takes Sun To Court Over Generic Eloxatin
- Huron, Empire Renew Bid To Toss St. Vincent FCA Suit
- Depomed Fights Generic Threat To Glumetza
- Fallon Clinic Joins Atrius After Deal With Mass. AG
- FDA Implements 9 Graphic Cigarette Warning Labels
- Cancer Patients Win $3M In Supplemental Coverage Suit
- Wyeth Settles Patent Suit Over Generic Effexor
- Kaneka Sues Over Q10 Supplement Patent In ITC
- Owner Of Ill. Weight Loss Clinics Charged With Fraud
- Fed. Circ. Tosses $5M Award Over Knee Surgery Patent
- Akin Gump Adds 2 Litigators To Health Industry Practice
- USPTO Widens Patent Prosecution Highway
- High Court Declines To Weigh In On Patent Definiteness
- Supreme Court To Weigh Patentability Again In Mayo Case
- GSK Sues Roxane, Watson Over Generic Avodart
- J&J Wins 1st Trial Victory In Levaquin MDL
- High Court Won't Review $58M Award In Wyeth Drug Suit
- Fed. Circ. Stops Launch Of Watson's Generic Seasonique
- How They Won It: Morgan Lewis Snags $577M Verdict For Asahi
- J&J Unit Recalls 40,000 Bottles Of Risperidone
- FDA Calls Back Boston Scientific Stents, Catheters
- HHS Wrongly Denied Hospital Reimbursements: DC Circ.
- Addus Homecare, Investors Reach $3M Deal Over IPO
- Technological Tying And 'Predatory' Innovation
- The Ultimate 'Shareholder'
- AstraZeneca Drops Suit After Teva Nixes Generic Faslodex
- Judge Won't Block Watson's Generic Seasonique
- How They Won It: Steptoe Gets Rare Acquittal For GSK Atty
- Somaxon Sues Zydus Over Generic Silenor
- GSK's Rotavirus Vaccine Tied To Bowel Disorder
- Q&A With Locke Lord's Graham Hill
- AGA Hits Occlutech With IP Suits In Germany, UK
- Inside Smith V. Bayer
- NH Senate Can't Make AG Join Health Reform Suit: Court
- NY Court Refuses To Step Between Prosecutors, Amgen
- FDA Says Chantix Raises Risk Of Heart Attacks
- High Court Greenlights W.Va. Class Bid In Baycol Fight
- GAO Upholds $24B Humana Military Care Contract
- Apotex Can't Dodge Schering Suit Over Nasonex IP
- 8th Circ. Weighs Women's Right To Pursue Wyeth Claims
- Novartis, Roxane Settle Famvir Dispute
- GSK Shakes Humana Suit Over Avandia Injury Costs
- FDA Widens Recall Of Boston Scientific Catheters
- Exec Says US Can't Prove Intent In Bone Cement Case
- AmeriHealth Settles Eating Disorder Coverage Suit
- 3rd Circ. Affirms Dismissal Of Amgen Tying Suit
- FDA Warns Matrixx Over Zicam Marketing
- 9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit
- Family Seeks $5M From Attys Who Won Suit With Bribes
- Novartis, Sun Settle IP Suit Over Generic Focalin
- Does Your Company Need An IP Protection Audit?
- FTC Seeks More Details On Teva's $6.8B Cephalon Buy
- Alcon Sues Watson To Block Pataday Generic
- Wis. Drug Cos. Face Temporary Shutdown After Raid
- DOJ Subpoenas Gilead Over HIV Drugs
- Humira Patient Sues Abbott Over Fungal Infection
- Extra Damages Possible In $22M Stent Suit: Fed. Circ.
- 3rd Circ. Lets HHS Off Hook For Pa. Disability Costs
- WL Gore Slaps Bard With Suit Over Stent Patent
- Davis Polk Reps Aetna In $290M Genworth Buy
- Ex-Pfizer Reps Seek Classes For NY, Calif., Ill.
- Germany Suspends Takeda Diabetes Drug Actos
- Pharma Holdings Defendants Get 10 Days To Yield Docs
- Novo Settles Drug Marketing Claims For $26.7M
- FDA Says Prostate Drugs Can Cause Cancer
- Pfizer Sanctions Affirmed In Neurontin Antitrust MDL
- Whistleblower Protections Restored: Sylvester V. Parexel
- Q&A With Bose McKinney's Mary Feldhake
- Negotiated Rate Differential Meets Collateral Source Rule
- One Court's Cynical View Of The Legislative Process
- Warner Chilcott Sues Mylan Over Loestrin ANDA
- Jury Finds Against Baxter In Chinese Heparin Suit
- Prosthetics Maker Wins Stay In Gel Liner IP Suit
- Fed. Circ. Upholds Hako-Med's Loss In Patent Suit
- Zocor Dangerous In High Doses, FDA Warns
- FDA Takes First Step Toward Regulating Nanotechnology
- Roche, Genentech Sued Over Encryption Patent
- EU Court Adviser Sides With Merck In Patent Term Fight
- 2nd Circ. Affirms $11M Hit Against Taro Insider Traders
- Cancer Patients Triumph In Supplemental Coverage Action
- UCB Agrees To Pay $34M Over Epilepsy Drug Labeling
- Insurer Can't Shake $2.5M Payout In Sex Abuse Case
- Lilly Sues Hetero To Block Generic Strattera
- Essentials For Success In Arbitration
- Schering-Plough Denied Injunction In Sunscreen Suit
- Medical Food Makers Settle False Advertising Suit
- 11th Circ. Weighs Health Law's Individual Mandate
- Lilly Wins TRO Battle In Byetta Marketing Case
- Mass. Hospitals Beat Worker Wage-And-Hour Action
- Pfizer Unit Yanks Poultry Drug After FDA Arsenic Study
- 8th Circ. Again Upholds Catheter Maker's Antitrust Win
- Lawyer Dad Settles SEC Insider Trading Suit
- WellPoint Buys CareMore In Reported $800M Deal
- The Perils Of One Wrong Word In A Contract
- Forest Labs Sales Reps Win Class Cert. In OT Suit
- Blue Cross Michigan Can't Dodge DOJ Antitrust Suit
- Fla. Hospital Not Immune From FCA Suit, Judge Rules
- Insurer Sues Ill. Over State Health Insurance Contracts
- Lundbeck Settles Antitrust Suit Over Infant Heart Drugs
- Fed. Circ. Won't Review Saint-Gobain Loss In Scanner Suit
- Patent Reform Bill Makes USPTO Too Powerful: House Reps.
- Fed. Circ. Affirms Invalidity Of J&J Stent Patents
- Merge Insurer Fights Coverage Of Entire 3M Fee Award
- 1-800 Contacts Uses IP Attacks To Quash Rivals: Suit
- Clarifying Obligation To Report Drug Patent Agreements
- Life Partners Could Face Expanded SEC Suit
- 7th Circ. Questions Ex-Abbott Workers' ERISA Suit Bid
- Blue Cross Tries To Dodge Price-Fixing Action In Mich.
- McKesson, Hearst Inflated Drug Prices, Mich. AG Says
- Blue Cross Underpaid Texas Claims By $11M: Suit
- Inventors Get 1st Dibs On Gov't-Funded IP: High Court
- Fed. Circ. Won't Revive $25M VA Contract Fight
- AstraZeneca Settles DOL Sex Bias Pay Dispute
- FDA Warns Impax Over Drug Testing At Calif. Plant
- Judge Trims MRI Class Action Against State Farm
- US Specialty Seeks To Nix Coverage In Dental Co. Row
- SEC Says Calif. Atty Stole Info On $2.8B Abbott Deal
- J&J Ordered To Pay $327M Over Risperdal Marketing
- $200M WellCare Health Settlement Isn't Fair: Investor
- Takeda Drops Suit Over Macleods' Actos ANDA
- Matrixx, Zicam Fail To Shut Down Cold Remedy MDL
- Federal Economic Crime Investigator Joins Kilpatrick
- Calif. Assembly OKs Health Insurance Rate Regulation
- A Lower-Cost Alternative To Litigation
- American Medical Settles Suits Over $2.9B Endo Buy
- Calif. County Seeks To Give US Drug Price-Fixing Docs
- Pfizer Sues Watson Over Viagra ANDA
- Ex-Hospital Exec Embezzled $1.7M, Feds Say
- GSK Denied Quick Win In Flonase Antitrust Cases
- SEC Widens Insider Trading Case Against FDA Chemist
- Pfizer Sues Impax Over Detrol ANDA
- Ex-CHM Workers Can Bring Collective OT Action: Judge
- Zicam Inventor Arrested Over Unapproved Bird Flu Drug
- Insurer On The Hook For Hospital Sex Abuse: Judge
- Squire Sanders Nabs Health Care Prosecutor
- Ropes & Gray Snags Former Assistant US Atty
- Orthovita Shareholders Sue Over $316M Stryker Deal
- Goodell DeVries Opens Pa. Office With Ex-Dechert Attys
- Ill. Hospital Prevails In 7th Circ. Antitrust Case
- Implications Of Fed. Circ.'s Therasense Opinion
- Industry Pressure Points May Shape Final ACO Rule
- 6th Circ. Mulls US Authority In Health Care Act Appeal
- Becton To Take Inequitable Conduct Fight To High Court
- 1st Circ. Revives Blackstone FCA Kickback Case
- Obama Administration Backs House Patent Reform Bill
- Endo Sales Reps Win Conditional Cert. For OT Suit
- Allergan, Hi-Tech Settle IP Case Over Generic Combigan
- Breach Claims Over Ventas-Nationwide Health Deal Nixed
- ReGen Sues FDA Over Menaflex Clearance Repeal
- Hydroxycut MDL Claims Fall Short, Judge Says
- Gentiva To Pay $12.5M Over Medicare Fraud Claims
- FTC Signs Off On Grifols-Talecris Deal Divestitures